Xuekun Xing1 ,
Hui Wang2,
Lan Zhao2,
Yunxiao Bai2,
Fei Xie2,
Junjie He2,
Chenxi Lv2
1School of Public Health, Guilin Medical University, Guilin Guangxi 541199;
2Department of Life Sciences and Technology, Xinxiang Medical University, Xinxiang, Henan 453003, PR China.
For correspondence:- Xuekun Xing
Email: biyingxiao@163.com Tel:+8615637382107
Accepted: 22 April 2020
Published: 31 May 2020
Citation:
Xing X, Wang H, Zhao L, Bai Y, Xie F, He J, et al.
Niacin downregulates chemokine (c-c motif) ligand 2 (CCL2) expression and inhibits fat synthesis in rat liver cells. Trop J Pharm Res 2020; 19(5):977-982
doi:
10.4314/tjpr.v19i5.10
© 2020 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Abstract
Purpose: To elucidate the role of chemokine (c-c motif) ligand 2 (CCL2) in fat metabolism in hepatocytes.
Methods: Following partial hepatectomy, regenerated rat liver cells were isolated and cultured for 24 h were transfected with recombinant plasmid pEGFP-N1-CCL2 using liposomes. Niacin was added to the culture medium to inhibit fat synthesis. CCL2 expression was measured using western blot, while the expression of acly-coa synthetase long chain family 4 (ACSL4) and apolipoprotein E (ApoE) were assessed using real-time PCR.
Results: At 12 h after transfection, GFP-positive rates in the pEGFP-N1 and pEGFP-N1-CCL2 transfection groups were 42.4 ± 5.6 % and 45.1 ± 3.5 %, respectively. expression levels of CCL2 increased over time in pEGFP-N1 transfection group, pEGFP-N1-ccl2 transfection group, and niacin and pEGFP-N1-ccl2 transfection co-treatment group; however, CCL2 expression levels in the niacin and pEGFP-N1-ccl2 transfection co-treatment groups were similar to that of pEGFP-N1 transfection group, which were significantly lower than those of the pEGFP-N1-ccl2 transfection group. expression level trends of fat-related genes ACSL4 and ApoE were similar to that of CCL2.
Conclusion: Niacin downregulates the expression of CCL2, thereby inhibiting lipid synthesis in liver cells.
Keywords: Chemokine 2, Niacin, Hepatectomy, Lipid synthesis, Transfection